Zelboraf approved for use in Erdheim-Chester disease
(HealthDay)—Zelboraf (vemurafenib) has been approved by the U.S. Food and Drug Administration as the first drug to treat certain adults patients with Erdheim-Chester disease (ECD).
Nov 8, 2017
0
1